Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Erin Harris

Physician Assistant Jacksonville, FL Physician Assistant

NPI 1548531114 CMS profile 11037413

4479 Baymeadows Rd, Jacksonville, FL 32217

Open in the dashboard

General payments

$7,370

350 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Erin Harris of Jacksonville, FL is reported in the CMS Open Payments database as having received $7,370 across 350 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,218 55
2024 General $1,670 70
2023 General $1,791 79
2022 General $1,613 82
2021 General $1,078 64

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Erin Harris
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Erin Harris were reported at $1,218. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Erin Harris Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $1,078 $132 $37–$438 $132
2022 $1,613 $155 $48–$522 $149
2023 $1,791 $167 $52–$557 $160
2024 $1,670 $178 $55–$600 $164
2025 $1,218 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $1,577 67 payments
  2. Janssen Biotech, Inc. $960 67 payments
  3. Genzyme Corporation $692 22 payments
  4. Regeneron Healthcare Solutions, Inc. $663 29 payments
  5. Sun Pharmaceutical Industries Inc. $613 25 payments
  6. Novartis Pharmaceuticals Corporation $554 26 payments
  7. Mayne Pharma Inc. $334 15 payments
  8. Incyte Corporation $221 10 payments
  9. Pfizer Inc. $163 10 payments
  10. Ortho Dermatologics, a division of Bausch Health US, LLC $159 8 payments
  11. Other $1,434 71 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $7,270 349 payments
  2. Education $100 1 payment
Products named General payments · program years 2021–2025
  1. DUPIXENT Immunology $929 29 payments
  2. SKYRIZI $738 31 payments
  3. TREMFYA $738 51 payments
  4. RINVOQ $585 23 payments
  5. DUPIXENT Inflammation And Immunology $392 17 payments
  6. ILUMYA $257 10 payments
  7. COSENTYX $230 10 payments
  8. SIMPONI ARIA $223 16 payments
  9. STELARA $223 16 payments
  10. REMICADE $223 16 payments
  11. Other $3,684 193 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

350 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record